Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
NCT ID: NCT00770614
Last Updated: 2012-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
450 participants
INTERVENTIONAL
2004-03-31
2008-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Hydration in Acute Myocardial Infarction
NCT01742130
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
NCT00639912
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
NCT00606827
PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION
NCT00130598
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection
NCT00700375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Sodium Bicarbonate (154 mEq/L in dextrose and H2O) 3 mL/kg for 1 hour before contrast medium, followed by an infusion of 1 mL/kg/h for 12 hours after the procedure
sodium bicarbonate solution
154 mEq/L in dextrose and H2O
2
Isotonic Saline (0.9% sodium chloride) 1 mL/kg/h for 12 hours after the procedure
Isotonic saline
0.9% sodium chloride
3
Placebo
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sodium bicarbonate solution
154 mEq/L in dextrose and H2O
Isotonic saline
0.9% sodium chloride
Placebo
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* previous contrast exposure within 72 hours
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ospedale Misericordia e Dolce
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mauro Maioli
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mauro Maioli, MD
Role: PRINCIPAL_INVESTIGATOR
Ospedale Misericordia e Dolce, Prato
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale Misericordia e Dolce
Prato, Prato, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
POCARD0703
Identifier Type: -
Identifier Source: secondary_id
Prato0703
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.